meta(y, v, x, data, intercept.constraints = NULL, coef.constraints = NULL,
RE.constraints = NULL, RE.startvalues=0.1, RE.lbound = 1e-10,
intervals.type = c("z", "LB"), I2="I2q", R2=TRUE,
model.name="Meta analysis with ML", suppressWarnings = TRUE,
silent = TRUE, run = TRUE, ...)t(as.matrix(intercept.constraints)). The default is that the intas.matrix(). The default is that all $m$ predictors predict all $p$ effect sizes. The
format of thisas.matrix(). The default is that all
covariance/variance components are free. The format of this maNAz (default if missing) or
LB. If it is z, it calculates the 95% Wald confidence
intervals (CIs) based on the z statistic. If it is LB, it
calculates the 95% likelihood-based CIs on the
paramet"I2q", "I2hm" and
"I2am". They represent the I2 calculated by using a
typical within-study sampling variance from the Q statistic, the
harmonic mean and the arithmatic mean of theTRUE and there are predictors, R2 is
calculated (Raudenbush, 2009).mxModel.TRUE, warnings are
suppressed. Argument to be passed to mxRun.mxRunFALSE, only return the mx model without
running the analysis.mxRunmeta with a list ofmatch.callTRUEmxRunmxRunCheung, M. W.-L. (2009). Constructing approximate confidence intervals for parameters with structural equation models. Structural Equation Modeling, 16, 267-294.
Cheung, M. W.-L. (2013). Multivariate meta-analysis as structural equation models. Structural Equation Modeling, 20, 429-454. Hardy, R. J., & Thompson, S. G. (1996). A likelihood approach to meta-analysis with random effects. Statistics in Medicine, 15, 619-629. Neale, M. C., & Miller, M. B. (1997). The use of likelihood-based confidence intervals in genetic models. Behavior Genetics, 27, 113-120.
Raudenbush, S. W. (2009). Analyzing effect sizes: random effects models. In H. M. Cooper, L. V. Hedges, & J. C. Valentine (Eds.), The handbook of research synthesis and meta-analysis (2nd ed., pp. 295-315). New York: Russell Sage Foundation.
Xiong, C., Miller, J. P., & Morris, J. C. (2010). Measuring study-specific heterogeneity in meta-analysis: application to an antecedent biomarker study of alzheimer's disease. Statistics in Biopharmaceutical Research, 2(3), 300-309. doi:10.1198/sbr.2009.0067
reml, Hox02,
Berkey98, wvs94a